Anaphylaxis News

Epinephrine autoinjector administration competence varied among caregivers, indicating a need for better education, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Symptomology varies among adults with anaphylaxis depending on the trigger, according to a study published in International Archives of Allergy and Immunology.

This year brought breakthroughs and important advances in asthma and allergy. Healio’s most popular stories in 2024 covered the long-anticipated approval of neffy epinephrine nasal spray and an update to anaphylaxis practice parameters.

A New York State Assemblymember celebrated the signing of two of her new bills into law that aim to expand epinephrine autoinjector accessibility across the state.

Healio has compiled November’s most read news in asthma and allergy.

BOSTON — Patients using lipid-lowering medications experienced increased anaphylaxis severity, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Allergen-related symptoms resolved within 5 minutes after an oral allergen challenge with the Anaphylm sublingual epinephrine strip from Aquestive Therapeutics, according to a press release from the company.

BOSTON — Consensus criteria for anaphylaxis diagnosis are moving toward more objective assessments of symptoms, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — There is a need for more education in recognizing anaphylaxis among patients with allergies, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ORLANDO — A need for allergy labeling, disparities in epinephrine access and knowledge gaps were found among Head Start centers, according to an abstract presented at the American Academy of Pediatrics National Conference & Exhibition.